CHRS
Coherus Oncology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CHRS fundamentals
Coherus Oncology (CHRS) released its earnings on Nov 6, 2025: revenue was 11.60M (YoY -83.61%), missed estimates; EPS was -0.33 (YoY -3200.00%), missed estimates.
Revenue / YoY
11.60M
-83.61%
EPS / YoY
-0.33
-3200.00%
Report date
Nov 6, 2025
CHRS Earnings Call Summary for Q3,2025
Key Takeaways
- Revenue Growth: LOQTORZI Q3 revenue $11.2M (92% YoY), targeting $150-200M peak by 2028.
- Pipeline Momentum:
- CHS-114 Phase II trials in 4 solid tumors; Q1 2026 data expected.
- Casdozokitug shows 38% ORR in HCC; Q1 2026 readouts.
- Financial Strength: $192M cash, 69% YoY liability reduction, <140 FTEs by year-end.
- Commercial Expansion: 15% sales force growth, digital campaigns to penetrate community oncologists.
- Strategic Focus: Treg depletion leadership; global partnerships to offset development costs.
EPS
Revenue
Revenue & Expenses
CHRS has released its 2025 Q3 earnings report, with revenue of 11.57M, reflecting a YoY change of 91.19%, and net profit of -35.53M, showing a YoY change of -230.49%. The Sankey diagram below clearly presents CHRS's revenue sources and cost distribution.
Key Indicators
Coherus Oncology (CHRS) key financial stats and ratios, covering profitability, financial health, and leverage.
Coherus Oncology (CHRS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Coherus Oncology (CHRS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Coherus Oncology (CHRS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Coherus Oncology (CHRS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Coherus Oncology (CHRS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Coherus Oncology do and what are its main business segments?What were the key takeaways from Coherus Oncology’s earnings call?What is Coherus Oncology's gross profit margin?What is the revenue and EPS growth rate for Coherus Oncology year over year?Did Coherus Oncology beat or miss consensus estimates last quarter?What guidance did Coherus Oncology's management provide for the next earnings period?What factors drove the changes in Coherus Oncology's revenue and profit?What is the market's earnings forecast for Coherus Oncology next quarter?
